共 50 条
- [2] IDENTIFYING RISK FACTORS FOR NON-PRESCRIPTION PDE-5 INHIBITOR USE IN ADULT MEN JOURNAL OF UROLOGY, 2023, 209 : E1142 - E1143
- [3] ERECTILE FUNCTION, PDE-5 USE AND SEXUAL DESIRE IN A LARGE COHORT OF UNTREATED HYPOGONADAL MEN: BASELINE FINDINGS FROM THE REGISTRY OF HYPOGONADISM IN MEN (RHYME) JOURNAL OF SEXUAL MEDICINE, 2014, 11 : 193 - 193
- [4] CLINICAL FEATURES OF LONG-TERM USE OF PDE-5 INHIBITORS IN PATIENTS WITH ED JOURNAL OF SEXUAL MEDICINE, 2013, 10 : 216 - 216
- [5] ASSOCIATION OF FEMALE SEXUAL FUNCTION WITH MALE PARTNERS' ERECTILE FUNCTION JOURNAL OF SEXUAL MEDICINE, 2013, 10 : 193 - 193
- [8] The dual 5α-reductase inhibitor dutasteride is safe and effective in men with benign prostatic hyperplasia receiving a PDE-5 inhibitor JOURNAL OF UROLOGY, 2004, 171 (04): : 360 - 360
- [10] PREDICTORS OF NON-PRESCRIPTION PDE-5 INHIBITOR USE IN ADULT MEN - RESULTS OF A COMMUNITY-BASED SURVEY JOURNAL OF SEXUAL MEDICINE, 2023, 20